PedAM
Pediatric Disease Annotations & Medicines
| Disease | c syndrome |
| Phenotype | C0022658|kidney disease |
| Sentences | 33 |
| PubMedID- 24991817 | Logistic regression models were used to estimate the odds and 95% confidence intervals of chronic kidney disease associated with individual components, metabolic syndrome, the number of components, and specific combinations of metabolic syndrome components. |
| PubMedID- 22773754 | These new findings establish the poko mouse as a good model for understanding the early events leading to kidney disease associated with metabolic syndrome. |
| PubMedID- 24211756 | Metabolic syndrome in children with chronic kidney disease: pon1 and treatment modality. |
| PubMedID- 20411291 | Hyperuricemia and metabolic syndrome: associations with chronic kidney disease. |
| PubMedID- 22997914 | [remodeling of the cardiovascular system and development of chronic kidney disease in patients with metabolic syndrome and obesity: role of enos, subunit p22-phox of nadph-oxidase and mthfr genes]. |
| PubMedID- 22218124 | Autosomal dominant polycystic kidney disease (adpkd) with nephrotic syndrome is a rare coincidence. |
| PubMedID- 24661755 | Aims: chronic kidney disease (ckd) due to metabolic syndrome has recently become a social problem in japan. |
| PubMedID- 24463862 | The objective of our study is to analyse whether circulating levels of supar are useful for identifying primary kidney disease in patients with nephrotic syndrome secondary to fsgs, minimal change disease or idiopathic membranous nephropathy (mn). |
| PubMedID- 21051748 | Urinary cystatin c as a potential risk marker for cardiovascular disease and chronic kidney disease in patients with obesity and metabolic syndrome. |
| PubMedID- 21801716 | The multivariate-adjusted odds ratio (or) of chronic kidney disease in participants with metabolic syndrome was 1.293 (95% ci 1.093-1.529) compared with those without. |
| PubMedID- 23760991 | Metabolic syndrome in children with chronic kidney disease and after renal transplantation. |
| PubMedID- 20061374 | Background: the aims of this study are to examine the prevalence of chronic kidney disease (ckd) with metabolic syndrome (ms) and to investigate the association between ckd and ms after adjustment for socioeconomic position and health behavior factor. |
| PubMedID- 20483511 | Diagnostic strategy relies on the clinical presentation: acute renal failure, chronic kidney disease, glomerular proteinuria with or without nephrotic syndrome, tubular proteinuria, hydroelectrolytic disorders. |
| PubMedID- 20682757 | Conclusion: although the frequency of cardiovascular risk factors and metabolic syndrome were high in patients with chronic kidney disease, they were negatively correlated with the stage of renal failure. |
| PubMedID- 23206870 | End-stage kidney disease due to haemolytic uraemic syndrome--outcomes in 241 consecutive anzdata registry cases. |
| PubMedID- 21912024 | Prevalence of chronic kidney disease in adults with metabolic syndrome. |
| PubMedID- 24719803 | Plasma level of adpn is suggested as a predictive marker of metabolic syndrome in patients with chronic kidney disease (ckd) who did not undergo dialysis (1). |
| PubMedID- 23834048 | Introduction: obesity, as a central piece inside metabolic syndrome, is associated with early chronic kidney disease (ckd). |
| PubMedID- 20014332 | Conclusions: the metabolic syndrome was associated with kidney disease even in subjects without major classical risk factors for chronic kidney disease. |
| PubMedID- 23459155 | Tanaka and colleagues showed that metabolic syndrome was significantly associated with chronic kidney disease among japaneese participants aged 30–79 years in a hospital-based screening program in okinawa [27]. |
| PubMedID- 24011327 | Serum fatty acid patterns, insulin sensitivity and the metabolic syndrome in individuals with chronic kidney disease. |
| PubMedID- 22470847 | Metabolic syndrome leading to chronic kidney disease: an emerging threat. |
| PubMedID- 25018933 | However, small, observational studies with short-term follow-up have suggested a benefit, mostly in subjects with a rapidly progressive course, often associated with extensive crescents, or in those with progressive kidney disease with persistence of severe nephrotic syndrome.145, 317, 323, 324, 325, 326, 327, 328, 329 publication bias might be operative in these reports. |
| PubMedID- 20429898 | We report the case of a 35-year-old indo-aryan man with autosomal dominant polycystic kidney disease associated with nephrotic syndrome and a concomitant decline in his glomerular filtration rate. |
| PubMedID- 25550967 | Association between the dietary factors and metabolic syndrome with chronic kidney disease in chinese adults. |
| PubMedID- 25931365 | Dimethylarginines as risk markers of atherosclerosis and chronic kidney disease in children with nephrotic syndrome. |
| PubMedID- 23120831 | [glomerular kidney disease that is associated with nephrotic syndrome or rapidly advancing renal failure]. |
| PubMedID- 25304295 | Relationship between tg/hdl-c ratio and metabolic syndrome risk factors with chronic kidney disease in healthy adult population. |
| PubMedID- 24624345 | Moreover, many epidemiological studies have suggested that hyperuricemia, which may be an independent risk factor for metabolic syndrome [4], is associated with kidney disease, cardiovascular disease [5], cerebrovascular disease [6], obesity, diabetes, hypertriglyceridemia, and hypertension. |
| PubMedID- 21116827 | Autosomal dominant polycystic kidney disease (adpkd) associated with steroid-sensitive nephrotic syndrome in childhood. |
| PubMedID- 24189077 | Risk factors for mau and kidney diseases include components of the metabolic syndrome (ms) 13–16 and lower ses. |
| PubMedID- 22997915 | [the role of hyperinsulinemia and insulin resistance in development of chronic kidney disease in patients with metabolic syndrome]. |
| PubMedID- 20047632 | The cardiometabolic syndrome has been associated with both chronic kidney disease (ckd) and cardiovascular disease (cvd). |
Page: 1